article: PMC2696716](/pmc/articles/PMC2696716/)\] \[[PubMed: 19633758](https://pubmed.ncbi.nlm.nih.gov/19633758)\] 49. Pfister R, Schneider CA. Natriuretic peptides BNP and NT-pro-BNP: established laboratory markers in clinical practice or just perspectives? Clin Chim Acta. 2004 Nov;349(1-2):25-38. \[[PubMed: 15469852](https://pubmed.ncbi.nlm.nih.gov/15469852)\] 50. Horio T, Shimada K, Kohno M, Yoshimura T, Kawarabayashi T, Yasunari K, Murakawa K, Yokokawa K, Ikeda M, Fukui T. Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty. Am Heart J. 1993 Aug;126(2):293-9. \[[PubMed: 8337997](https://pubmed.ncbi.nlm.nih.gov/8337997)\] 51. Arakawa N, Nakamura M, Aoki H, Hiramori K. Relationship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology. 1994;85(5):334-40. \[[PubMed: 7850823](https://pubmed.ncbi.nlm.nih.gov/7850823)\] 52. Ozturk TC, Unluer E, Denizbasi A, Guneysel O, Onur O. Can NT-proBNP be used as a criterion for heart failure hospitalization in emergency room? J Res Med Sci. 2011 Dec;16(12):1564-71. \[[PMC free article: PMC3434897](/pmc/articles/PMC3434897/)\] \[[PubMed: 22973364](https://pubmed.ncbi.nlm.nih.gov/22973364)\] 53. Wang K, Ojamaa K, Samuels A, Gilani N, Zhang K, An S, Zhang Y, Tang YD, Askari B, Gerdes AM. BNP as a New Biomarker of Cardiac Thyroid Hormone Function. Front Physiol. 2020;11:729. \[[PMC free article: PMC7363952](/pmc/articles/PMC7363952/)\] \[[PubMed: 32733267](https://pubmed.ncbi.nlm.nih.gov/32733267)\] 54. Francis GS, Felker GM, Tang WH. A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure. J Am Coll Cardiol. 2016 Jan 26;67(3):330-7. \[[PMC free article: PMC4928678](/pmc/articles/PMC4928678/)\] \[[PubMed: 26796399](https://pubmed.ncbi.nlm.nih.gov/26796399)\] 55. Seino Y, Ogawa A, Yamashita T, Fukushima M, Ogata K, Fukumoto H, Takano T. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail. 2004 Mar 15;6(3):295-300. \[[PubMed: 14987579](https://pubmed.ncbi.nlm.nih.gov/14987579)\] 56. Savarese G, Musella F, D'Amore C, Vassallo E, Losco T, Gambardella F, Cecere M, Petraglia L, Pagano G, Fimiani L, Rengo G, Leosco D, Trimarco B, Perrone-Filardi P. Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis. JACC Heart Fail. 2014 Apr;2(2):148-58. \[[PubMed: 24720923](https://pubmed.ncbi.nlm.nih.gov/24720923)\] 57. Kelly R, Struthers AD. Are natriuretic peptides clinically useful as markers of heart failure? Ann Clin Biochem. 2001 Sep;38(Pt 5):575-83. \[[PubMed: 11587142](https://pubmed.ncbi.nlm.nih.gov/11587142)\] 58. Nishikimi T, Nakagawa Y. Potential pitfalls when interpreting plasma BNP levels in heart failure practice. J Cardiol. 2021 Oct;78(4):269-274. \[[PubMed: 34088563](https://pubmed.ncbi.nlm.nih.gov/34088563)\] 59. Badrick T. The quality control system. Clin Biochem Rev. 2008 Aug;29 Suppl 1(Suppl 1):S67-70. \[[PMC free article: PMC2556587](/pmc/articles/PMC2556587/)\] \[[PubMed: 18852861](https://pubmed.ncbi.nlm.nih.gov/18852861)\] 60. Bruno LC. IQCP: Guideline and Helpful Tools for Implementation. Lab Med. 2016 Nov;47(4):e42-e46. \[[PubMed: 27708173](https://pubmed.ncbi.nlm.nih.gov/27708173)\] 61. Westgard JO, Westgard SA. Establishing Evidence-Based Statistical Quality Control